Awakn Life Sciences (OTC:AWKNF), a clinical-stage biotechnology company specializing in the development of ketamine-assisted treatments for addiction, has entered into a global licensing agreement ...

VANCOUVER, British Columbia, June 22, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery is pleased to ...

VANCOUVER, British Columbia, April 12, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV) a specialty pharmaceutical company is pleased to announce that has completed the final ...

PHOENIX, AZ, Feb 07, 2012 (MARKETWIRE via COMTEX) -- Kedem Pharmaceuticals Inc. KDMP -4.17% , a specialty pharmaceutical company with focus on sublingual drug delivery is pleased to participate ...

The company is developing Anaphylm, a sublingual Epinephrine film to treat anaphylactic reactions. The sublingual route has the advantage of rapid onset of action with direct entry into the systemic ...

Subcutaneous allergen-specific immunotherapy has long been used in allergic rhinitis and/or asthma and has been recognized to be efficacious. However, owing to the inconvenience of injection and the ...

One vaccine, three routes for activating the entire immune system and providing T cell, B cell memory, and mucosal protection The first COVID-19 vaccine trials designed to deliver both S and N ...

December 16, 2009 (Buenos Aires, Argentina) — A new study shows that sublingual immunotherapy against grass pollen allergy not only provides symptom relief during the period of administration, it also ...

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study A total of 114 patients were randomly ...

GoNitro Espero announced that the Food and Drug Administration (FDA) has approved GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to ...